---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-010652"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2023-04-03T23:59:59+00:00"
generated_at: "2026-06-17T06:58:39.050140+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# RenovoRx raises $5M in registered direct offering and private placement of common stock and warrants

## Summary
- Gross proceeds of ~$5M from sale of 1,557,632 shares (or pre-funded warrants) at $3.21 per share.
- Concurrent private placement of warrants to purchase 1,947,040 shares at $3.21, exercisable for 5.5 years.
- Offering priced at-the-market under Nasdaq rules; closing on April 3, 2023.
- Roth Capital Partners acted as exclusive placement agent; net proceeds for working capital and general corporate purposes.
- Pre-funded warrants priced at $3.2099 each to avoid investor exceeding 4.99% beneficial ownership.

## SEC filing metadata
- accession: 0001493152-23-010652
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2023-04-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315223010652/0001493152-23-010652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315223010652/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-010652
- JSON: https://secwatch.observer/filing/0001493152-23-010652.json
- Plain text: https://secwatch.observer/filing/0001493152-23-010652.txt

## Key facts
- Material Agreements
  RenovoRx, Inc. entered into Securities Purchase Agreement with a certain institutional investor valued at approximately $5.00 million (effective 2023-03-30).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain institutional investor
  - Value: approximately $5.00 million
  - Effective: 2023-03-30
  source text: On March 30, 2023, RenovoRx, Inc. (the “ Company ,” “ we ” or “ us ”) entered into a securities purchase agreement (“ Securities Purchase Agreement ”) with a certain institutional investor (“ Purchaser ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315223010652/0001493152-23-010652-index.htm
- Material Agreements
  RenovoRx, Inc. entered into Placement Agreement with Roth Capital Partners, LLC (effective 2023-03-30).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Roth Capital Partners, LLC
  - Effective: 2023-03-30
  source text: Roth Capital Partners, LLC (the “ Placement Agent ”) acted as the exclusive placement agent for the Offerings, pursuant to a placement agency agreement (the “ Placement Agreement ”), dated March 30, 2023, by and between the Company and the Placement Agent.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1574094/000149315223010652/0001493152-23-010652-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.